Toward biosimilar monoclonal antibodies
To what extent is the existing framework for biosimilars in Europe likely to be applicable to monoclonal antibodies?
Gespeichert in:
| Veröffentlicht in: | Nature biotechnology 2008-09, Vol.26 (9), p.985-990 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 990 |
|---|---|
| container_issue | 9 |
| container_start_page | 985 |
| container_title | Nature biotechnology |
| container_volume | 26 |
| creator | Schneider, Christian K Kalinke, Ulrich |
| description | To what extent is the existing framework for biosimilars in Europe likely to be applicable to monoclonal antibodies? |
| doi_str_mv | 10.1038/nbt0908-985 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69529111</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69529111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-cbee682c4702691a4a8501ed0900b2cfa0149a6bf39ad4dcfb19873cef3ba8b33</originalsourceid><addsrcrecordid>eNptkE1LxDAQhoMo7rp68i6LBz1odaZp0-Qoi1-w4GU9hyRNpUvbrEmL-O-NtLAgnmZgHt55eQg5R7hDoPy-0z0I4Ing-QGZY56xBJlgh3EHXiSAOZuRkxC2AMAyxo7JDHlRCA5sTq437kv5cqlrF-q2bpRftq5zpnGdapaq62vtytqGU3JUqSbYs2kuyPvT42b1kqzfnl9XD-vE0Bz7xGhrGU9NVkDKBKpM8RzQlrEg6NRUCjATiumKClVmpak0Cl5QYyuqFdeULsjVmLvz7nOwoZdtHYxtGtVZNwTJRJ4KRIzg5R9w6wYfSweZpikFWmARoZsRMt6F4G0ld75ulf-WCPJXnpzkySgv0hdT5KBbW-7ZyVYEbkcgxFP3Yf3-5395P-jOeAU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222303717</pqid></control><display><type>article</type><title>Toward biosimilar monoclonal antibodies</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Nature Journals Online</source><creator>Schneider, Christian K ; Kalinke, Ulrich</creator><creatorcontrib>Schneider, Christian K ; Kalinke, Ulrich</creatorcontrib><description>To what extent is the existing framework for biosimilars in Europe likely to be applicable to monoclonal antibodies?</description><identifier>ISSN: 1087-0156</identifier><identifier>EISSN: 1546-1696</identifier><identifier>DOI: 10.1038/nbt0908-985</identifier><identifier>PMID: 18779806</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>Agriculture ; Antibodies, Monoclonal - chemistry ; Antibodies, Monoclonal - immunology ; Antibody Specificity - immunology ; Biochemistry ; Bioinformatics ; Biomedical and Life Sciences ; Biomedical Engineering/Biotechnology ; Biomedical Research ; Biomedicine ; Biotechnology ; Chemistry, Pharmaceutical - legislation & jurisprudence ; Chemistry, Pharmaceutical - methods ; commentary ; Committees ; Drug Approval ; Drug Design ; Drug Industry - legislation & jurisprudence ; Drug Industry - methods ; Drug Industry - trends ; Europe ; Humans ; Life Sciences ; Pharmaceutical industry ; R&D ; Regulation ; Research & development</subject><ispartof>Nature biotechnology, 2008-09, Vol.26 (9), p.985-990</ispartof><rights>Springer Nature America, Inc. 2008</rights><rights>Copyright Nature Publishing Group Sep 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c351t-cbee682c4702691a4a8501ed0900b2cfa0149a6bf39ad4dcfb19873cef3ba8b33</citedby><cites>FETCH-LOGICAL-c351t-cbee682c4702691a4a8501ed0900b2cfa0149a6bf39ad4dcfb19873cef3ba8b33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/nbt0908-985$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/nbt0908-985$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18779806$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schneider, Christian K</creatorcontrib><creatorcontrib>Kalinke, Ulrich</creatorcontrib><title>Toward biosimilar monoclonal antibodies</title><title>Nature biotechnology</title><addtitle>Nat Biotechnol</addtitle><addtitle>Nat Biotechnol</addtitle><description>To what extent is the existing framework for biosimilars in Europe likely to be applicable to monoclonal antibodies?</description><subject>Agriculture</subject><subject>Antibodies, Monoclonal - chemistry</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>Antibody Specificity - immunology</subject><subject>Biochemistry</subject><subject>Bioinformatics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering/Biotechnology</subject><subject>Biomedical Research</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Chemistry, Pharmaceutical - legislation & jurisprudence</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>commentary</subject><subject>Committees</subject><subject>Drug Approval</subject><subject>Drug Design</subject><subject>Drug Industry - legislation & jurisprudence</subject><subject>Drug Industry - methods</subject><subject>Drug Industry - trends</subject><subject>Europe</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Pharmaceutical industry</subject><subject>R&D</subject><subject>Regulation</subject><subject>Research & development</subject><issn>1087-0156</issn><issn>1546-1696</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkE1LxDAQhoMo7rp68i6LBz1odaZp0-Qoi1-w4GU9hyRNpUvbrEmL-O-NtLAgnmZgHt55eQg5R7hDoPy-0z0I4Ing-QGZY56xBJlgh3EHXiSAOZuRkxC2AMAyxo7JDHlRCA5sTq437kv5cqlrF-q2bpRftq5zpnGdapaq62vtytqGU3JUqSbYs2kuyPvT42b1kqzfnl9XD-vE0Bz7xGhrGU9NVkDKBKpM8RzQlrEg6NRUCjATiumKClVmpak0Cl5QYyuqFdeULsjVmLvz7nOwoZdtHYxtGtVZNwTJRJ4KRIzg5R9w6wYfSweZpikFWmARoZsRMt6F4G0ld75ulf-WCPJXnpzkySgv0hdT5KBbW-7ZyVYEbkcgxFP3Yf3-5395P-jOeAU</recordid><startdate>20080901</startdate><enddate>20080901</enddate><creator>Schneider, Christian K</creator><creator>Kalinke, Ulrich</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>M7S</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20080901</creationdate><title>Toward biosimilar monoclonal antibodies</title><author>Schneider, Christian K ; Kalinke, Ulrich</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-cbee682c4702691a4a8501ed0900b2cfa0149a6bf39ad4dcfb19873cef3ba8b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Agriculture</topic><topic>Antibodies, Monoclonal - chemistry</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>Antibody Specificity - immunology</topic><topic>Biochemistry</topic><topic>Bioinformatics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering/Biotechnology</topic><topic>Biomedical Research</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Chemistry, Pharmaceutical - legislation & jurisprudence</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>commentary</topic><topic>Committees</topic><topic>Drug Approval</topic><topic>Drug Design</topic><topic>Drug Industry - legislation & jurisprudence</topic><topic>Drug Industry - methods</topic><topic>Drug Industry - trends</topic><topic>Europe</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Pharmaceutical industry</topic><topic>R&D</topic><topic>Regulation</topic><topic>Research & development</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schneider, Christian K</creatorcontrib><creatorcontrib>Kalinke, Ulrich</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schneider, Christian K</au><au>Kalinke, Ulrich</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Toward biosimilar monoclonal antibodies</atitle><jtitle>Nature biotechnology</jtitle><stitle>Nat Biotechnol</stitle><addtitle>Nat Biotechnol</addtitle><date>2008-09-01</date><risdate>2008</risdate><volume>26</volume><issue>9</issue><spage>985</spage><epage>990</epage><pages>985-990</pages><issn>1087-0156</issn><eissn>1546-1696</eissn><abstract>To what extent is the existing framework for biosimilars in Europe likely to be applicable to monoclonal antibodies?</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>18779806</pmid><doi>10.1038/nbt0908-985</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1087-0156 |
| ispartof | Nature biotechnology, 2008-09, Vol.26 (9), p.985-990 |
| issn | 1087-0156 1546-1696 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69529111 |
| source | MEDLINE; SpringerLink Journals; Nature Journals Online |
| subjects | Agriculture Antibodies, Monoclonal - chemistry Antibodies, Monoclonal - immunology Antibody Specificity - immunology Biochemistry Bioinformatics Biomedical and Life Sciences Biomedical Engineering/Biotechnology Biomedical Research Biomedicine Biotechnology Chemistry, Pharmaceutical - legislation & jurisprudence Chemistry, Pharmaceutical - methods commentary Committees Drug Approval Drug Design Drug Industry - legislation & jurisprudence Drug Industry - methods Drug Industry - trends Europe Humans Life Sciences Pharmaceutical industry R&D Regulation Research & development |
| title | Toward biosimilar monoclonal antibodies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T01%3A07%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Toward%20biosimilar%20monoclonal%20antibodies&rft.jtitle=Nature%20biotechnology&rft.au=Schneider,%20Christian%20K&rft.date=2008-09-01&rft.volume=26&rft.issue=9&rft.spage=985&rft.epage=990&rft.pages=985-990&rft.issn=1087-0156&rft.eissn=1546-1696&rft_id=info:doi/10.1038/nbt0908-985&rft_dat=%3Cproquest_cross%3E69529111%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222303717&rft_id=info:pmid/18779806&rfr_iscdi=true |